| Kelsey Nagel, MS CCC-SLP | |
|
10939 Field Crescent Cir, Noblesville, IN 46060-6108 | |
| (317) 938-3419 | |
| (317) 938-3419 |
| Full Name | Kelsey Nagel |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 10939 Field Crescent Cir, Noblesville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477063451 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22006536A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelsey Nagel, MS CCC-SLP 10939 Field Crescent Cir, Noblesville, IN 46060-6108 Ph: (317) 938-3419 | Kelsey Nagel, MS CCC-SLP 10939 Field Crescent Cir, Noblesville, IN 46060-6108 Ph: (317) 938-3419 |
News Archive
Cancer Therapeutics, Inc. (OTCBB: CTHP), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, LLC which would give Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.
Joan M. O'Brien, MD, the George E. de Schweinitz and William F. Norris Professor of Ophthalmology, chair of the Department of Ophthalmology and director of the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania, was recently presented with the Women in Ophthalmology's Suzanne Veronneau Troutman Award.
Kemin Foods, L.C. ("Kemin") and OmniActive Health Technologies, Inc. and OmniActive Health Technologies, Ltd. ("OmniActive") have reached an amicable settlement of their dispute.
The first data offering health care professionals a better look into the genetic basis of certain types of adverse drug events was released today by the FDA and the International Serious Adverse Event Consortium (SAEC).
Transgene SA, a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and infectious diseases, today announced that favourable pre-clinical and clinical data on two Transgene products - TG1050 and TG4040 to treat chronic hepatitis B and chronic hepatitis C, respectively - will be presented in oral presentations at this year's European Association for the Study of the Liver Conference (Amsterdam, Netherlands, April 24-28, 2013).
› Verified 5 days ago
Mrs. Jennifer Ann Logan Maiden, M.ED CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5170 Gateway Ave, Noblesville, IN 46062 Phone: 317-432-4247 Fax: 317-877-6618 | |
Angela Kathryn Adams, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18758 Round Lake Rd, Noblesville, IN 46060 Phone: 317-774-3377 Fax: 317-774-3377 | |
Mrs. Erin H. Bradley, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11383 Lucky Dan Dr, Noblesville, IN 46060 Phone: 317-443-7556 Fax: 317-842-9500 | |
Tina Marie Scoble, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10340 Pleasant St Ste 100, Noblesville, IN 46060 Phone: 317-776-9000 Fax: 317-776-9016 | |
Shelby Elise Doty, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9155 E 146th St, Noblesville, IN 46060 Phone: 317-379-6618 | |
Leann Faust, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15316 Evanston Close, Noblesville, IN 46062 Phone: 317-508-8662 | |
Melissa Lynn Hendrickson, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 517 N 9th St, Noblesville, IN 46060 Phone: 317-506-0061 |